alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
I 

118TH CONGRESS 

2D SESSION H. R. 7414 

To require the development of a national strategy to secure schools against 

terrorism nationwide, and ensure domestic preparedness for and the 

response to terrorism, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 20, 2024 

Mr. TONY GONZALES of Texas (for himself and Mr. GOTTHEIMER) introduced 

the following bill; which was referred to the Committee on Homeland Security 

A BILL 

To require the development of a national strategy to secure 

schools against terrorism nationwide, and ensure domestic preparedness for and the response to terrorism, and 

for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘National Strategy for 

5 School Security Act of 2024’’. 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
2 

•HR 7414 IH

1 SEC. 2. NATIONAL STRATEGY TO SECURE SCHOOLS FROM 

2 THREATS OF TERRORISM. 

3 (a) IN GENERAL.—To assist in the domestic pre4 paredness for and response to acts of terrorism and to 

5 coordinate Federal efforts to secure elementary and sec6 ondary schools (as such terms are defined in section 8101 

7 of the Elementary and Secondary Education Act of 1965 

8 (20 U.S.C. 7801)), not later than 180 days after the date 

9 of the enactment of this Act, the Secretary of Homeland 

10 Security, in consultation and cooperation with the Sec11 retary of Education and the heads of other appropriate 

12 Federal agencies and departments, shall develop and sub13 mit to the Committee on Homeland Security and the Com14 mittee on Education and the Workforce of the House of 

15 Representatives and the Committee on Homeland Security 

16 and Governmental Affairs and the Committee on Health, 

17 Education, Labor, and Pensions of the Senate a national 

18 school security strategy including, as appropriate, updates 

19 to such strategy. 

20 (b) CONTENTS.—The strategy required under sub21 section (a) shall— 

22 (1) account and describe all Federal programs, 

23 projects, and activities, including spending levels, to 

24 secure elementary and secondary schools from acts 

25 of terrorism; 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
3 

•HR 7414 IH

1 (2) identify specific school security 

2 vulnerabilities from acts of terrorism within the 

3 United States, and delineate goals for closing such 

4 security vulnerabilities; 

5 (3) describe actions to be taken to achieve such 

6 goals and the means necessary to do so, including 

7 steps to reform, improve, and streamline existing ef8 forts to align the current threat environment to 

9 schools; and 

10 (4) identify new authorities or changes in exist11 ing authorities required to address school security. 

12 (c) SUNSET.—The requirement to transmit updated 

13 national strategies under this section shall terminate on 

14 the date that is seven years after the date of the enact15 ment of this Act. 

Æ 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
Editorial Note on Part 172
Editorial Note: Nomenclature changes to part 172 appear at 61 FR 14482, Apr. 2, 1996; 66 FR 56035, Nov. 6, 2001; 66 FR 66742, Dec. 27, 2001; 68 FR 15355, Mar. 31, 2003; 70 FR 40880, July 15, 2005; 70 FR 67651, Nov. 8, 2005; 70 FR 72074, Dec. 1, 2005; and 81 FR 49896, July 29, 2016.

§ 172.828 Acetylated monoglycerides. The food additive acetylated monoglycerides may be safely used in or on food in accordance with the following prescribed conditions: ( a ) The additive is manufactured by: ( 1 ) The interesterification of edible fats with triacetin and in the presence of catalytic agents that are not food additives or are authorized by regulation, followed by a molecular distillation or by steam stripping; or
( 2 ) The direct acetylation of edible monoglycerides with acetic anhydride without the use of catalyst or molecular distillation, and with the removal by vacuum distillation, if necessary, of the acetic acid, acetic anhydride, and triacetin.
( b ) The food additive has a Reichert-Meissl value of 75-200 and an acid value of less than 6.
( c ) The food additive is used at a level not in excess of the amount reasonably required to produce its intended effect in food, or in food-processing, food-packing, or food-storage equipment.
[42 FR 14491, Mar. 15, 1977, as amended at 50 FR 3508, Jan. 25, 1985]
§ 510.305 Maintenance of copies of approved medicated feed mill licenses to manufacture animal feed bearing or containing new animal drugs. Each applicant shall maintain in a single accessible location: ( a ) A copy of the approved medicated feed mill license (Form FDA 3448) on the premises of the manufacturing establishment; and
( b ) Approved or index listed labeling for each Type B and/or Type C feed being manufactured on the premises of the manufacturing establishment or the facility where the feed labels are generated.
[64 FR 63203, Nov. 19, 1999, as amended at 72 FR 69121, Dec. 6, 2007]
§ 26.42 Exchange and endorsement of product evaluation reports. ( a ) European Community (EC) conformity assessment bodies (CAB's) listed for this purpose will, subject to the specifications and limitations on the list, provide to FDA 510(k) premarket notification assessment reports prepared to U.S. medical device requirements.
( b ) U.S. CAB's will, subject to the specifications and limitations on the list, provide to the EC Notified Body of the manufacturer's choice, type examination, and verification reports prepared to EC medical device requirements.
( c ) Based on the determination of equivalence in light of the experience gained, the product evaluation reports prepared by the CAB's listed as equivalent will normally be endorsed by the importing party, except under specific and delineated circumstances. Examples of such circumstances include indications of material inconsistencies, inadequacies, or incompleteness in a product evaluation report, or other specific evidence of serious concern in relation to product safety, performance, or quality. In such cases, the importing party may request clarification from the exporting party which may lead to a request for a reevaluation. The parties will endeavor to respond to requests for clarification in a timely manner. Endorsement remains the responsibility of the importing party.
# I . Spill Bucket Performance

- Spill Buckets have a useful life of 5 - 8 years. Many ofthe buckets installed for the 1998 upgrade deadline are nearing the end of their useful lives. 

## to -k..\6>



### ~k 

## <U-- '1.'3' \ 

### o~s - 

### £~~~~ 

## \oo-z. Q \ () S - \"Zd\L



### ~ **ct€.~ ~**  **(3A&(t!'~"p** - A survey of inspection results estimated 8.4% of spill buckets G:;6t" were leaking in 2003 - 2004



### -~ **c.~c\~, \~'tP~**  **c~~** 

## , **R-s~~"~ ~"~** 

- Fuel and dirt in the bucket can significantly shorten the life of the bucket. Regular maintenance can extend the life. 

### .- 

### ~.s~\~

- Spill bucket replacement is expensive: $1500 for materials and labor, the cost of an environmental investigation, and the cost of a cleanup ifcontamination is found Sp ill Bucket -----4.- **'~** Dale S toud emire South Carolina D epartm e nt of Health and Environm e ntal C ontrol 260 0 Bull S t Columbia S C 292 01 803-8 96-68 44 s tou dedw(a ).d he c. sc .go v
# L_2022015EN.01002101.xml

| 24.1.2022 | EN | Official Journal of the European Union | L 15/21 |
| --- | --- | --- | --- |

24.1.2022

EN

Official Journal of the European Union

L 15/21

---

Corrigendum to Commission Directive (EU) 2019/1831 of 24 October 2019 establishing a fifth list of indicative occupational exposure limit values pursuant to Council Directive 98/24/EC and amending Commission Directive 2000/39/EC

(
  Official Journal of the European Union L 279 of 31 October 2019
  )

On page 34, Annex, in the table, the 10th row (Phosphoryl trichloride):

for:

| ‘233-046-7 | 10025-87-3 | Phosphoryl trichloride | 0,064 | 0,01 | 0,12 | 0,02 | —’ |
| --- | --- | --- | --- | --- | --- | --- | --- |

‘233-046-7

10025-87-3

Phosphoryl trichloride

0,064

0,01

0,12

0,02

—’

read:

| ‘233-046-7 | 10025-87-3 | Phosphoryl trichloride | 0,064 | 0,01 | 0,13 | 0,02 | —’ |
| --- | --- | --- | --- | --- | --- | --- | --- |

‘233-046-7

10025-87-3

Phosphoryl trichloride

0,064

0,01

0,13

0,02

—’

---
#### Inheritance Tax on Escheatable Funds

January 15, 1951.

Umsted, Deputy Attorney General,

You have requested this department to advise you if registers of wills should collect inheritance tax on escheatable funds coming to the Commonwealth from decedents’ estates.

Escheatable funds of decedents come to the Commonwealth, either by escheat under the Act of May 2, 1889, P. L. 66, as amended, 27 PS §§41 et seq., or without escheat under section 1314 of The Fiscal Code of April 9, 1929, P. L. 343, 72 PS §1314, or as an heir under section 3 of the Intestate Act of April 24, 1947, P. L. 80, 20 PS §1.3. In each case the funds initially come to the Commonwealth, although in any case they may be subject to refund. Where the funds are had under the Escheat Act of 1889 the adjudication may be opened within three years under section 22, 27 PS §91, *45and the funds paid to the rightful owner. Where the Commonwealth takes under the Intestate Act of 1947, refund may be had within seven years under section 13, 20 PS §1.13. Where the Commonwealth takes under The Fiscal Code, supra, refund may be made at any time under section 504, 72 PS §504; Rhodes v. Hannebauer Estates, 71 D. & C. 330 (1950); Davis Estate, 365 Pa. 605 (1950).

Section 1 of the Act of June 20, 1919, P. L. 521, as last amended by the Act of May 11, 1949, P. L. 1083, 72 PS §2301, reads, in part, as follows:

“A tax shall be, and is hereby, imposed upon the transfer of any property, real or personal, or of any interest therein or income therefrom in trust or otherwise, to persons or corporations in the following cases:

*“(a)*When the transfer is by will or by the intestate laws of this Commonwealth from any person dying seized or possessed of the property while a resident of the Commonwealth, whether the property be situated within this Commonwealth or elsewhere.”

It is to be noted that the inheritance tax is imposed only where there is a transfer of property “to persons or corporations”.

That such language in a statute does not include the Commonwealth of Pennsylvania is made abundantly clear by Deputy Attorney General Keitel in Formal Opinion No. 304, dated November 13,1939, to the Pennsylvania Liquor Control Board, 1939-1940 Op. Atty. Gen. 122, where many cases to this effect are cited, starting with Commonwealth v. Yeakel, 1 Woodward 143, 144 (1863), where the rule is stated as follows:

“. . . In a general law passed in order to regulate the rights and duties of citizens, the sovereign is not embraced unless included in the express terms of the statute. . . .”

Until then, escheatable funds are about to pass into the hands of individuals or corporations, under the re*46fund provisions of the acts above indicated, there is no tax due.

We are of the opinion and you are accordingly advised that inheritance tax should not be collected by registers of wills on escheatable funds going to the Commonwealth, either by escheat, without escheat or as an heir. Refund of such funds to persons or corporations are, however, subject to inheritance tax at the rate fixed by law.
§ 211.25 Personnel qualifications. ( a ) Each person engaged in the manufacture, processing, packing, or holding of a drug product shall have education, training, and experience, or any combination thereof, to enable that person to perform the assigned functions. Training shall be in the particular operations that the employee performs and in current good manufacturing practice (including the current good manufacturing practice regulations in this chapter and written procedures required by these regulations) as they relate to the employee's functions. Training in current good manufacturing practice shall be conducted by qualified individuals on a continuing basis and with sufficient frequency to assure that employees remain familiar with CGMP requirements applicable to them.
( b ) Each person responsible for supervising the manufacture, processing, packing, or holding of a drug product shall have the education, training, and experience, or any combination thereof, to perform assigned functions in such a manner as to provide assurance that the drug product has the safety, identity, strength, quality, and purity that it purports or is represented to possess.
( c ) There shall be an adequate number of qualified personnel to perform and supervise the manufacture, processing, packing, or holding of each drug product.
Editorial Note on Part 177
Editorial Note: Nomenclature changes to part 177 appear at 61 FR 14482, Apr. 2, 1996; 66 FR 56035, Nov. 6, 2001; 66 FR 66742, Dec. 27, 2001; 68 FR 15355, Mar. 31, 2003; 70 FR 72074, Dec. 1, 2005; and 81 FR 49896, July 29, 2016.

§ 177.2355 Mineral reinforced nylon resins. Mineral reinforced nylon resins identified in paragraph (a) of this section may be safely used as articles or components of articles intended for repeated use in contact with nonacidic food (pH above 5.0) and at use temperatures not exceeding 212 °F. in accordance with the following prescribed conditions: ( a ) For the purpose of this section the mineral reinforced nylon resins consist of nylon 66, as identified in and complying with the specifications of § 177.1500, reinforced with up to 40 weight percent of calcium silicate and up to 0.5 weight percent 3-(triethoxysilyl) propylamine (Chemical Abstracts Service Registry No. 000919302) based on the weight of the calcium silicate.
( b ) The mineral reinforced nylon resins may contain up to 0.2 percent by weight of titanium dioxide as an optional adjuvant substance.
( c ) The mineral reinforced nylon resins with or without the optional substance described in paragraph (b) of this section, and in the form of 1 ⁄ 8-inch molded test bars, when extracted with the solvents, i.e., distilled water and 50 percent (by volume) ethyl alcohol in distilled water, at reflux temperature for 24 hours using a volume-to-surface ratio of 2 milliliters of solvent per square inch of surface tested, shall meet the following extractives limitations: ( 1 ) Total extractives not to exceed 5.0 milligrams per square inch of food-contact surface tested for each solvent.
( 2 ) The ash after ignition of the extractives described in paragraph (c)(1) of this section, not to exceed 0.5 milligram per square inch of food-contact surface tested.
( d ) In accordance with good manufacturing practice, finished articles containing the mineral reinforced nylon resins shall be thoroughly cleansed prior to their first use in contact with food.
[42 FR 54533, Oct. 7, 1977, as amended at 42 FR 61594, Dec. 6, 1977]
Order filed January 27, 2015 

In The

Fourteenth Court of Appeals

____________

NO. 14-13-01013-CR

____________

MAHMOUD AFHAMI, Appellant

V.

THE STATE OF TEXAS, Appellee

On Appeal from the County Criminal Court at Law No 13

Harris County, Texas

Trial Court Cause No. 1892708

ORDER

This court has determined, pursuant to Texas Rule of Appellate Procedure 

34.5(f) and 34.6(g)(2), that it must inspect the original of State's Exhibit 1, a CD.
The clerk of the County Criminal Court at Law No 13 is directed to deliver 

to the Clerk of this court the original of State's Exhibit 1, a CD, on or before 

February 06, 2015. The Clerk of this court is directed to receive, maintain, and 

keep safe this original exhibit; to deliver it to the justices of this court for their 

inspection; and, upon completion of inspection, to return the original of State's 

Exhibit 1, a CD, to the clerk of the County Criminal Court at Law No 13.

 

PER CURIAM
Petition under Section 333 of the FAA Modernization Act of 2012 (FRMA) for 

waiver of Airworthiness Certificate

Petitioner plans on operating an Unmanned Aircraft, more specifically a DJI Phantom 3 

Professional, for the following purposes:

1. To take videos or photographs of homes, commercial buildings, land or lots for sale to 

be used in marketing said properties.

2. For inspection of buildings, normally roof and gutters, for owners.

3. To take videos or photographs of watercraft for owners or for newsworthy purposes.

4. To inspect bridges, roads and railroads for maintenance purposes or such purposes 

requested by owners which may be government entities.

5. Aircraft may be used at times by the owner for recreational purposes for which the air 

certificate is not required.

Operation of the unmanned aircraft will be:

1. At altitudes not to exceed 400 feet.

2. Visible to operator at all times.

3. Due consideration will be made for the safety of persons in the area of operation. In 

most cases, it is anticipated there will be no persons under the flight path of the aircraft.

4. In accordance with manufacturer’s instructions.

5. By an operator trained in operation of this aircraft.

6. Operated only outside a 3 miles radius of any airport.

7. Limited to weather which does not impede visibility or have winds over 20 mph.

Pre-flight Inspection and maintenance will be in accordance with the manufacture’s written 

procedures.

The DJI Phantom 3 Professional weighs less than 3 pounds, and has a top speed of 35 mph. It 

possesses speed, altitude and GPS information which is displayed on the operator’s consol. It 

also has a “go home” capability which will return it to the location the flight started from.

Petitioner seeks an exemption of the Airworthiness Certificate under the authority granted to

the Secretary by Section 333.
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7426 Introduced in House (IH)]

<DOC>

118th CONGRESS
  2d Session
                                H. R. 7426

To amend part A of title IV of the Social Security Act to target funds 
                          to families in need.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           February 20, 2024

Mr. Smith of Nebraska introduced the following bill; which was referred 
                   to the Committee on Ways and Means

_______________________________________________________________________

                                 A BILL

 
To amend part A of title IV of the Social Security Act to target funds 
                          to families in need.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Targeting TANF to Families in Need 
Act''.

SEC. 2. TARGETING FUNDS TO FAMILIES IN NEED.

    (a) In General.--Section 404 of the Social Security Act (42 U.S.C. 
604) is amended by adding at the end the following:
    ``(l) Establishing a Threshold for Families in Need.--A State to 
which a grant is made under section 403(a)(1) shall use the grant only 
to provide assistance or services to a family whose income is less than 
twice the poverty guidelines updated periodically in the Federal 
Register under section 673(2) of the Omnibus Budget Reconciliation Act 
of 1981 (42 U.S.C. 9902(2)).''.
    (b) Effective Date.--The amendment made by subsection (a) shall 
take effect on October 1, 2025.

SEC. 3. TWO-YEAR REAUTHORIZATION OF THE TEMPORARY ASSISTANCE FOR NEEDY 
              FAMILIES PROGRAM.

    Activities authorized by part A of title IV (other than under 
section 403(c) or 418) and section 1108(b) of the Social Security Act 
shall continue through September 30, 2026, in the manner authorized for 
fiscal year 2023, and out of any money in the Treasury of the United 
States not otherwise appropriated, there are hereby appropriated such 
sums as may be necessary for such purpose.
                                 <all>
```
7 Hanover Square
                                                    New York, NY 10004-2616
                                                    212 422-1000
                                                    FAX 212 422-0144


                                        (logo)Grant Thornton
                                Grant Thornton LLP  Accountants and     
                                                    Management Consultants

                    INDEPENDENT ACCOUNTANTS' REPORT The U.S. Member Firm of
                                                    Grant Thornton lnternational



To the Board of Directors
    DALE MORTGAGE BANKERS CORP.



We have examined  management's  assertion  about Dale Mortgage  Bankers  Corp.'s
compliance with minimum servicing  standards  identified in the Mortgage Bankers
Association of America's UNIFORM SINGLE ATTESTATION PROGRAM FOR MORTGAGE BANKERS
(USAP)  as of and for the  year  ended  December  31,  1995,    included  in the
accompanying management assertion.  Management is responsible for Dale  Mortgage
Bankers  Corp.'s  compliance  with  those  minimum  servicing   standards.   Our
responsibility  is to express an opinion  on  management's  assertion  about the
entity's compliance based on our examination.

Our  examination  was  made in  accordance  with  standards  established  by the
American  Institute of Certified Public Accountants and,  accordingly,  included
examining,   on a test  basis,  evidence  about Dale  Mortgage  Bankers  Corp.'s
compliance  with the  minimum  servicing  standards  and  performing  such other
procedures as we considered necessary in the circumstances.  We believe that our
examination  provides a reasonable  basis for our opinion.  Our examination does
not provide a legal  determination on Dale Mortgage  Bankers Corp.'s  compliance
with minimum servicing standards.

In our opinion, management's assertion that Dale Mortgage Bankers Corp. complied
with the aforementioned minimum servicing standards as of and for the year ended
December 31, 1995, is fairly stated in all material respects.



/s/Grant Thornton LLP


New York, New York
March 25, 1996
§ 516.28 Publication of MUMS-drug designations. FDA will periodically update a publicly available list of MUMS-designated drugs. This list will be placed on file at the FDA Dockets Management Staff, and will contain the following information for each MUMS-designated drug: ( a ) The name and address of the sponsor;
( b ) The established name and trade name, if any, of the drug;
( c ) The dosage form of the drug;
( d ) The species and the proposed intended use for which MUMS-drug designation was granted; and
( e ) The date designation was granted.
[72 FR 41017, July 26, 2007, as amended at 88 FR 45066, July 14, 2023]